The study revealed a pattern of decreased expression of DNMT genes (DNMT3A and DNMT3B) and an increase in the methylation of the TNF-α and TLR4 promoters in COVID-19 patients, as well as a correlation between global methylation and disease severity. This evidence concerns the gene DNMT1 and COVID-19.